Primary sclerosing cholangitis: Refinement and validation of survival models

E. Rolland Dickson, Paul A. Murtaugh, Russell H. Wiesner, Patricia M. Grambsch, Thomas R. Fleming, Jurgen Ludwig, Nicholas F La Russo, Michael Malinchoc, Roger W. Chapman, Marshall M. Kaplan, Willis C. Maddrey, Roger Williams, Mark Farrant, Alice Langworthy

Research output: Contribution to journalArticle

224 Scopus citations

Abstract

The natural history of primary sclerosing cholangitis was studied in 426 patients from five medical centers. The median follow-up time was 3.0 years (range, 0.01-16.6 years); 100 patients had died by the time of last follow-up. Survival analysis (Cox proportional-hazards regression) was used to identify the variables most useful in predicting survival of patients with primary sclerosing cholangitis. Serum bilirubin concentration, histological stage on liver biopsy, age, and the presence of splenomegaly were independent predictors of a high risk of dying. A mathematical model to predict survival of patients with primary sclerosing cholangitis (based on referral values of those predictors) was statistically validated using two methods. Confidence intervals for predicting patient-specific survival probabilities are also presented. This model to predict survival could be used to stratify participants in therapeutic trials, counsel patients and their families, decide on candidacy for and timing of liver transplantation, and provide mathematical controls for evaluating the efficacy of therapies for primary sclerosing cholangitis, including transplantation.

Original languageEnglish (US)
Pages (from-to)1893-1901
Number of pages9
JournalGastroenterology
Volume103
Issue number6
StatePublished - 1992

    Fingerprint

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Dickson, E. R., Murtaugh, P. A., Wiesner, R. H., Grambsch, P. M., Fleming, T. R., Ludwig, J., La Russo, N. F., Malinchoc, M., Chapman, R. W., Kaplan, M. M., Maddrey, W. C., Williams, R., Farrant, M., & Langworthy, A. (1992). Primary sclerosing cholangitis: Refinement and validation of survival models. Gastroenterology, 103(6), 1893-1901.